Related Experiment Video

Updated: Jul 18, 2026

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
05:50

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Published on: June 2, 2023

Is osteoarthritis an infection-associated disease and a target for chemotherapy?

Alexander Rozin1

  • 1B. Shine Department of Rheumatology, Rambam Medical Center, B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. a_rozin@ambam.health.gov.il

Chemotherapy
|December 29, 2006
PubMed

Insights

Osteoarthritis (OA) treatment is challenging. This study suggests OA may be infection-associated, proposing cotrimoxazole (sulfamethoxazole/trimethoprim) as a potential therapy due to its anti-inflammatory effects.

Area of Science:

  • Rheumatology
  • Immunology
  • Infectious Diseases

Background:

  • Osteoarthritis (OA) poses significant treatment challenges, with current therapies often yielding disappointing results.
  • Emerging evidence highlights the role of inflammatory cytokines in OA progression, necessitating novel therapeutic strategies.
  • Cotrimoxazole, a combination antibiotic, exhibits anti-inflammatory properties and is utilized in treating autoimmune conditions.

Purpose of the Study:

  • To explore the potential of cotrimoxazole as a therapeutic agent for osteoarthritis (OA).
  • To investigate the hypothesis that OA and degenerative joint/spine diseases are infection-associated conditions.

Main Methods:

  • Review of existing literature and clinical experience regarding OA pathogenesis and treatment.
  • Analysis of the anti-inflammatory properties of cotrimoxazole (sulfamethoxazole/trimethoprim).
  • Evaluation of the potential application of cotrimoxazole in managing OA and related degenerative diseases.

Main Results:

  • Cotrimoxazole possesses documented anti-inflammatory characteristics.
  • The study posits a potential link between OA, degenerative joint disease, and infectious processes.
  • Sulfamethoxazole/trimethoprim is proposed as a viable therapeutic option for these conditions.

Conclusions:

  • Osteoarthritis and degenerative joint/spine diseases may be associated with infections.
  • Cotrimoxazole (sulfamethoxazole/trimethoprim) presents a promising therapeutic target for these conditions based on its anti-inflammatory actions.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...